✦ LIBER ✦

Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients

✍ Scribed by José Oberholzer; Eunice John; Adisorn Lumpaopong; Giuliano Testa; Howard N. Sankary; Leslie Briars; Kerri A. Kraft; Peter S. Knight; Priya Verghese; Enrico Benedetti

Book ID: 110895890
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 141 KB
Volume: 9
Category: Article
ISSN: 1397-3142
DOI: 10.1111/j.1399-3046.2005.00319.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic syndrome in pediatric renal tr

Metabolic syndrome in pediatric renal transplant recipients: Comparing early discontinuation of steroids vs. steroid group

✍ Amy Maduram; Eunice John; Guillermo Hidalgo; Ramona Bottke; Linda Fornell; Jose 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Increased risk of post-transplant diabet

Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients

✍ Debra A Walczak; Denise Calvert; Tomasz M Jarzembowski; Giuliano Testa; Howard N 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Effects of growth hormone on kidney func

Effects of growth hormone on kidney function in pediatric transplant recipients

✍ Blanche M. Chavers; Leah Doherty; Thomas E. Nevins; Marie Cook; Kumud Sane 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 622 KB

Effective treatment of anemia in pediatr

Effective treatment of anemia in pediatric kidney transplant recipients with methoxy polyethylene glycol-epoetin beta

✍ Mirja Wedekin; Jochen H. H. Ehrich; Lars Pape 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Acyclovir plus CMV immunoglobulin prophy

Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients

✍ F. Ginevri; G. Losurdo; I. Fontana; A. M. Rabagliati; L. Bonatto; R. Valente; P. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 146 KB

Acyclovir plus CMV immunoglobulin prophy

Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients

✍ F. Ginevri; G. Losurdo; I. Fontana; A. M. Rabagliati; L. Bonatto; R. Valente; P. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 507 KB